Index

Johnson Matthey Pharmaceutical Materials Division

We are a part of Johnson Matthey's Pharmaceutical Materials Division alonside Johnson Matthey Macfarlan Smith, Johnson Matthey Pharma Services and Johnson Matthey Pharmaceutical Materials - USA.

Intertwining strength, leadership and technical capabilities, Johnson Matthey's worldwide Pharmaceutical Materials Division business units become one to resolve your API development and manufacturing challenges. Core cGMP and regulatory compliance standards serve as the basis for process research, development, optimization, scale-up, validation, custom synthesis, opiate production, natural product extraction, commercial manufacturing (mg - metric tons), worldwide controlled substances capabilities and full analytical and regulatory support in both Europe and the US.

Advantage
Our seamless, combined resources mean no tech transfer hassles across our state of the art facilities. They provide consistency you can rely on and the comfort that comes with strict confidentiality. We strive to form lasting relationships and the nature of our business means we will not compete with your business on any level.

Intelligence
Our robust, sophisticated science has its roots in our years of experience and our highly talented scientific professionals. Our large pool of expert Ph.D. and technical professionals produce innovative scientific solutions, driving your project to its goal as quickly and efficiently as possible.

Stability
We are Johnson Matthey, a company that has been in business for over 180 years. We are a strong reliable partner with eyes toward the future. We provide you with a sophisticated, stable infrastructure, a global supply chain and a devout commitment to enhancing our technologies and capabilities all along the way.

Quality
Individually each division member boasts exemplary quality control and regulatory compliance records. Together, our cumulative practice provides seamless, worry free control throughout the duration of your project.